Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 April 2013 12 April 2013Press releaseVeterinary Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2013 12 April 2013NewsHumanPharmacovigilance European Medicines Agency publishes report on patient recruitment and geographical location of clinical trials 9 April 2013NewsCorporateMedicines World Health Day on 7 April 2013: focus on high blood pressure 5 April 2013NewsCorporate European Medicines Agency welcomes new Head of Infrastructure Services 2 April 2013NewsCorporateMedicines European Medicines Agency to begin PSUR assessment based on active substances in both centrally and nationally authorised medicines 27 Marec 2013NewsCorporateMedicines Increased fees coming into effect on 1 April 2013 27 Marec 2013NewsCorporate European Medicines Agency updates procedural guidance in line with new pharmacovigilance legislation 26 Marec 2013NewsCorporateMedicines European Medicines Agency investigates findings on pancreatic risks with GLP-1-based therapies for type-2 diabetes 26 Marec 2013Press releaseCorporateCompliance and inspectionsMedicines European Medicines Agency closed 28 March - 1 April 2013 26 Marec 2013NewsCorporateMedicines 1 … 231 232 233 234 235 Page 235 of 384 236 237 238 239 … 384
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 9-11 April 2013 12 April 2013Press releaseVeterinary
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2013 12 April 2013NewsHumanPharmacovigilance
European Medicines Agency publishes report on patient recruitment and geographical location of clinical trials 9 April 2013NewsCorporateMedicines
European Medicines Agency welcomes new Head of Infrastructure Services 2 April 2013NewsCorporateMedicines
European Medicines Agency to begin PSUR assessment based on active substances in both centrally and nationally authorised medicines 27 Marec 2013NewsCorporateMedicines
European Medicines Agency updates procedural guidance in line with new pharmacovigilance legislation 26 Marec 2013NewsCorporateMedicines
European Medicines Agency investigates findings on pancreatic risks with GLP-1-based therapies for type-2 diabetes 26 Marec 2013Press releaseCorporateCompliance and inspectionsMedicines